Literature DB >> 22656427

Basal cell carcinoma of the prostate: a case report.

Gillian Stearns1, Jed-Sian Cheng, Oleg Shapiro, Imad Nsouli.   

Abstract

A 69-year-old man presented with gross hematuria and irritative urinary symptoms. He underwent transurethral resection of his prostate. The prostate chips revealed 70% poorly differentiated carcinoma with neuroendocrine features, initially read as small cell carcinoma, later as basal cell carcinoma. PSA at this time was 0.3. He received 4 cycles of etoposide and cisplatin. After which, rebiopsy of the prostate showed tumor consistent with poorly differentiated basal cell carcinoma. Given progression on chemotherapy, decision was made to proceed with radical prostatectomy. Metastatic workup was negative. Gross extraprostatic invasion was noted but lymph nodes were free of metastatic disease.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22656427     DOI: 10.1016/j.urology.2012.03.003

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  4 in total

1.  Primary basal cell carcinoma of the prostate with concurrent adenocarcinoma.

Authors:  David Hennes; Adrian Dragovic; James Sewell; Meng Yeong Hoh; Richard Grills
Journal:  IJU Case Rep       Date:  2020-01-14

2.  A Review Leveraging a Rare and Unusual Case of Basal Cell Carcinoma of the Prostate.

Authors:  Lin He; Christopher Metter; Vitaly Margulis; Payal Kapur
Journal:  Case Rep Pathol       Date:  2021-05-04

3.  An Unusual Case of Metastatic Basal Cell Carcinoma of the Prostate: A Case Report and Literature Review.

Authors:  Shiqiang Dong; Qing Liu; Zihan Xu; Haitao Wang
Journal:  Front Oncol       Date:  2020-05-27       Impact factor: 6.244

Review 4.  Adenoid Cystic Carcinoma/Basal Cell Carcinoma of the Prostate: Overview and Update on Rare Prostate Cancer Subtypes.

Authors:  Salvatore Cozzi; Lilia Bardoscia; Masoumeh Najafi; Andrea Botti; Gladys Blandino; Matteo Augugliaro; Moana Manicone; Federico Iori; Lucia Giaccherini; Angela Sardaro; Cinzia Iotti; Patrizia Ciammella
Journal:  Curr Oncol       Date:  2022-03-09       Impact factor: 3.677

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.